MyAverix Finance
HM · Healthcare
Haemato AG (HAEK)
Drug Manufacturers - Specialty & Generic
Haemato AG (HAEK) is listed on HM in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for HAEK
Haemato AG (HAEK) — FAQ
What is HAEK's P/E ratio?
The price-to-earnings (P/E) ratio for Haemato AG (HAEK) is 18.00 (data as of 2026-03-22).
Does Haemato AG pay a dividend?
Dividend yield is not available in the current snapshot for Haemato AG (HAEK). Check the MyAverix Finance app for the latest dividend data.
What sector is Haemato AG in?
Haemato AG (HAEK) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is HAEK listed on?
HAEK is listed on HM.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.